Table 1.
The most significant up-regulated and down-regulated GO Biological Process pathways from M. fortuitum-infected ALoCs containing macrophages
| Direction | GO Biological Process | Statistic | Genes | adj.Pval |
|---|---|---|---|---|
| Up | Response to bacterium | 7.3996 | 438 | 1.1e-09 |
| Humoral immune response | 6.5518 | 138 | 6.0e-07 | |
| Defense response to bacterium | 6.3097 | 169 | 1.1e-06 | |
| Antimicrobial humoral response | 6.0602 | 65 | 1.9e-05 | |
| Response to molecule of bacterial origin | 5.5061 | 251 | 3.7e-05 | |
| Chemotaxis | 5.2453 | 444 | 8.2e-05 | |
| Taxis | 5.2402 | 445 | 8.2e-05 | |
| Response to lipopolysaccharide | 5.2654 | 240 | 8.2e-05 | |
| Antimicrobial humoral immune response mediated by antimicrobial peptide | 5.6504 | 41 | 1.4e-04 | |
| Down | MRNA processing | −6.8939 | 402 | 4.4e-08 |
| RNA splicing | −6.5273 | 385 | 2.3e-07 | |
| Histone modification | −5.7112 | 429 | 1.6e-05 | |
| Proteasome-mediated ubiquitin-dependent protein catabolic process | −5.5755 | 410 | 2.5e-05 | |
| Proteasomal protein catabolic process | −5.534 | 470 | 2.5e-05 | |
| Chromatin organization | −5.4523 | 478 | 3.2e-05 | |
| NcRNA metabolic process | −5.3774 | 477 | 4.2e-05 | |
| Peptidyl-lysine modification | −5.128 | 343 | 1.5e-04 | |
| RNA splicing via transesterification reactions with bulged adenosine as nucleophile | −5.1146 | 265 | 1.5e-04 | |
| MRNA splicing via spliceosome | −5.1146 | 265 | 1.5e-04 | |
| RNA splicing via transesterification reactions | −5.097 | 269 | 1.5e-04 |